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Glioblastoma (GB, grade IV astrocytoma) is the most common and lethal brain 
tumor characterized by increased proliferation and resistance to chemotherapy and 
radiotherapy. GB infiltrates the brain, always relapses and leads to death within 2 
years from diagnosis. At cellular level, relapse and infiltration are correlated with 
the presence of GB precursors stem-like cells. At molecular level, relapse and infiltra-
tion are correlated with upregulation of the mammalian target of rapamycin, mTOR 
which constantly characterizes malignant gliomas.
By definition mTOR is strongly inhibited by rapamycin and rapalogs. Several 
studies were carried out to evaluate the effects of rapamycin in experimental models 
of GB. However, it remains controversial whether rapamycin and rapalogs produce 
cell differentiation or cell death.
Therefore, in the present study we used a wide range of doses of rapamycin to 
address the issue of differential effects obtained by rapamycin in various experi-
mental setting. In particular, rapamycin was administered ranging from 1 nM up to 
1microM to assess cell viability in GB cell lines (U87MG). All the experiments were 
carried out exposing the cells for 24 h to rapamycin.
We found that rapamycin produced dose dependently cell death which was signifi-
cant for doses starting at 100 nM and reaches a plateau at 1 microM (50% cell death).
Interestingly, when using rapamycin at doses between 1 nM and 100 nM we 
described only slight cell death while the prominent effect induced by rapamy-
cin consisted of cell differentiation. In detail, beta 3 tubulin increased, while nestin 
decreased under rapamycin exposure. These markers were related to phenotypic 
changes consisting of an increased number and length of cell processes along with 
the loss of fusiform cell shape.
In the process of characterizing the effects of mTOR up-regulation and its phar-
macological inhibition we also measured the accumulation of an mTOR-dependent 
protein such as alpha-synuclein. In fact, mTOR up-regulation is known to inhibit the 
autophagy pathway which removes alpha-synuclein. Consistently, in U87MG cells 
we found accumulation of alpha-synuclein which was removed dose dependently by 
rapamycin exposure.
Our data show that inhibiting mTOR with rapamycin is a powerful tool to induce 
cell differentiation in U87MG cells, whereas cell death significantly occurs only at the 
highest doses.
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